AU597478B2 - 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith - Google Patents
3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith Download PDFInfo
- Publication number
- AU597478B2 AU597478B2 AU12827/88A AU1282788A AU597478B2 AU 597478 B2 AU597478 B2 AU 597478B2 AU 12827/88 A AU12827/88 A AU 12827/88A AU 1282788 A AU1282788 A AU 1282788A AU 597478 B2 AU597478 B2 AU 597478B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- oxathiin
- hydrogen
- leukemia
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2465787A | 1987-03-11 | 1987-03-11 | |
| US024657 | 1987-03-11 | ||
| US07/146,512 US4822813A (en) | 1987-03-11 | 1988-01-21 | 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith |
| US146512 | 2002-05-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1282788A AU1282788A (en) | 1988-09-15 |
| AU597478B2 true AU597478B2 (en) | 1990-05-31 |
Family
ID=26698721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12827/88A Ceased AU597478B2 (en) | 1987-03-11 | 1988-03-09 | 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4822813A (enExample) |
| JP (1) | JPS63264580A (enExample) |
| AT (1) | AT397089B (enExample) |
| AU (1) | AU597478B2 (enExample) |
| BE (1) | BE1002181A3 (enExample) |
| CA (1) | CA1320210C (enExample) |
| CH (1) | CH674366A5 (enExample) |
| DE (1) | DE3808024A1 (enExample) |
| DK (1) | DK168707B1 (enExample) |
| ES (1) | ES2011075A6 (enExample) |
| FR (1) | FR2612188B1 (enExample) |
| GB (1) | GB2201958B (enExample) |
| GR (1) | GR1000238B (enExample) |
| IE (1) | IE61955B1 (enExample) |
| IL (1) | IL85517A (enExample) |
| IT (1) | IT8819726A0 (enExample) |
| LU (1) | LU87152A1 (enExample) |
| NL (1) | NL8800531A (enExample) |
| NZ (1) | NZ223798A (enExample) |
| SE (1) | SE466400B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9001327D0 (en) * | 1990-01-19 | 1990-03-21 | May & Baker Ltd | New compositions of matter |
| HRP921128B1 (en) * | 1991-10-30 | 1998-10-31 | Sandor Garaczy | Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof |
| CN106278845B (zh) * | 2016-05-19 | 2019-03-05 | 海正化工南通有限公司 | 一种3,5-二氯-2-戊酮的合成工艺 |
| CN106565441A (zh) * | 2016-11-10 | 2017-04-19 | 安徽国星生物化学有限公司 | 一种3,5‑二氯‑2‑戊酮的合成方法 |
| CN106673978B (zh) * | 2016-11-30 | 2019-06-25 | 湖南化工研究院有限公司 | 3,5-二氯-2-戊酮的连续化合成方法 |
| CN107473949B (zh) * | 2017-09-26 | 2020-10-02 | 安徽国星生物化学有限公司 | 一种3,5-二氯-2-戊酮的合成工艺 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3868459A (en) * | 1968-05-21 | 1975-02-25 | Aquitaine Petrole | Method of killing nematodes using certain halomethyl oxathienes |
| US3728357A (en) * | 1970-09-08 | 1973-04-17 | Uniroyal Inc | 2-(substituted-methyl)-5,6-dihydro-1,4-oxathiin-3-carboxamides |
| US4319003A (en) * | 1980-09-26 | 1982-03-09 | General Motors Corporation | Poly(methyl methacrylate) polycarbonate block copolymers |
-
1988
- 1988-01-21 US US07/146,512 patent/US4822813A/en not_active Expired - Lifetime
- 1988-02-23 IL IL85517A patent/IL85517A/xx not_active IP Right Cessation
- 1988-02-25 GB GB8804454A patent/GB2201958B/en not_active Expired - Fee Related
- 1988-03-02 NL NL8800531A patent/NL8800531A/nl not_active Application Discontinuation
- 1988-03-03 IE IE59788A patent/IE61955B1/en not_active IP Right Cessation
- 1988-03-08 GR GR880100136A patent/GR1000238B/el unknown
- 1988-03-08 CH CH869/88A patent/CH674366A5/de not_active IP Right Cessation
- 1988-03-08 NZ NZ223798A patent/NZ223798A/xx unknown
- 1988-03-09 AU AU12827/88A patent/AU597478B2/en not_active Ceased
- 1988-03-09 CA CA000560945A patent/CA1320210C/en not_active Expired - Fee Related
- 1988-03-09 LU LU87152A patent/LU87152A1/fr unknown
- 1988-03-10 SE SE8800863A patent/SE466400B/sv not_active IP Right Cessation
- 1988-03-10 BE BE8800274A patent/BE1002181A3/fr not_active IP Right Cessation
- 1988-03-10 IT IT8819726A patent/IT8819726A0/it unknown
- 1988-03-10 DK DK131188A patent/DK168707B1/da not_active IP Right Cessation
- 1988-03-10 DE DE3808024A patent/DE3808024A1/de not_active Withdrawn
- 1988-03-10 FR FR888803118A patent/FR2612188B1/fr not_active Expired - Lifetime
- 1988-03-10 JP JP63055123A patent/JPS63264580A/ja active Granted
- 1988-03-11 AT AT0067688A patent/AT397089B/de not_active IP Right Cessation
- 1988-03-11 ES ES8800731A patent/ES2011075A6/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB8804454D0 (en) | 1988-03-23 |
| IE61955B1 (en) | 1994-11-30 |
| FR2612188A1 (fr) | 1988-09-16 |
| IT8819726A0 (it) | 1988-03-10 |
| ES2011075A6 (es) | 1989-12-16 |
| DE3808024A1 (de) | 1988-09-22 |
| DK131188D0 (da) | 1988-03-10 |
| SE466400B (sv) | 1992-02-10 |
| DK168707B1 (da) | 1994-05-24 |
| JPS63264580A (ja) | 1988-11-01 |
| GR880100136A (en) | 1989-01-31 |
| ATA67688A (de) | 1993-06-15 |
| CA1320210C (en) | 1993-07-13 |
| JPH0372221B2 (enExample) | 1991-11-18 |
| CH674366A5 (enExample) | 1990-05-31 |
| GR1000238B (el) | 1992-05-12 |
| IL85517A0 (en) | 1988-08-31 |
| SE8800863D0 (sv) | 1988-03-10 |
| AU1282788A (en) | 1988-09-15 |
| LU87152A1 (fr) | 1988-11-17 |
| US4822813A (en) | 1989-04-18 |
| NL8800531A (nl) | 1988-10-03 |
| DK131188A (da) | 1988-09-12 |
| NZ223798A (en) | 1989-12-21 |
| SE8800863L (sv) | 1989-09-12 |
| AT397089B (de) | 1994-01-25 |
| IE880597L (en) | 1988-09-11 |
| GB2201958A (en) | 1988-09-14 |
| BE1002181A3 (fr) | 1990-10-02 |
| FR2612188B1 (fr) | 1991-02-15 |
| IL85517A (en) | 1992-09-06 |
| GB2201958B (en) | 1990-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6013626A (en) | Cryptophycins from synthesis | |
| US6656943B2 (en) | 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands | |
| DE60022227T2 (de) | 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung | |
| US5952298A (en) | Cryptophycins | |
| EP0037486A2 (en) | Metal chelates of 1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones | |
| EP0721336B1 (en) | Benzazole compounds for use in therapy | |
| US5874431A (en) | Benzazole compounds | |
| EP0303951B1 (de) | 2-Pyrimidinyl-1-piperazin-Derivate zur Behandlung von Alkoholismus | |
| DE69428620T2 (de) | Benzoxazule Derivate und ihre Anwendung als Serotonin 5HT3 Rezeptor Antagonisten | |
| US4822813A (en) | 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith | |
| KR910009934B1 (ko) | 카르바모일-2-피롤리디논 화합물 | |
| CH642351A5 (de) | Antihypertensive, schwefel enthaltende verbindungen, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| EP0869786B1 (en) | Pharmaceutical compounds | |
| US20020128185A1 (en) | Pharmaceutical compounds | |
| CN116419753B (zh) | 作为bcl-2抑制剂的杂环化合物 | |
| US4468520A (en) | 3-Cyano-indoles as cardioselective agents | |
| FR2576595A1 (fr) | Composes acylaminoalcanoyliques a action antihypertensive et analgesique | |
| DE3014011A1 (de) | Benzo-as-triazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| FR2485531A1 (fr) | Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
| DE69517593T2 (de) | Polymorphe a und b des 1-(piphenylmethyl)-4-[3-(2-phenyl-dioxolan-2-yl)propyl]piperazins | |
| SU668275A1 (ru) | Производные 5-оксиалкил-5,10-дигидропиридазино [3,4-в] хиноксалина, обладающие противоопухолевой активностью | |
| KR20050084438A (ko) | 치환된 벤조디옥세핀 | |
| CA2214565C (en) | New cryptophycins from synthesis | |
| EP0594036A1 (de) | Arylalkoxythiocumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| FR2568878A1 (fr) | Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique |